Pfizer to merge off-patent drug unit Upjohn with Mylan in all-stock deal The Seattle Times
Pfizer agreed Monday to combine its off-patent drugs division, which controls treatments like the statin Lipitor, with the pharmaceutical company Mylan, creating …